宝鸡市人民政府关于印发《宝鸡市卫生县城卫生镇村考核奖励暂行办法》的通知

上一篇: 安徽省人民政府关于修改《安徽省森林和野生动物类型自然保护区管理办法》等规章的决定
下一篇: 交通运输部关于调整完善黑龙江省内贸货物经俄罗斯港口运至我国东南沿海港口试点工作相关政策的公告

State Food and Drug Administration General Administration of Customs of the People’s Republic of China


Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)




(SFDA Decree No. 25)

The Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim), adopted by the State Food and Drug Administration, the General Administration of Customs of the People’s Republic of China and the General Administration of Sport of China, is hereby promulgated in the decree sequence number of the State Food and Drug Administration and shall come into force as of September 1, 2006.


Shao Mingli
Commissioner
State Food and Drug Administration

Mou Xinsheng
Minister
General Administration of Customs of the People’s Republic of China

Liu Peng
Minister
General Administration of Sport of China
July 28, 2006





Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)


Article 1 The Provisions are formulated with a view to standardizing the administration of import and export of anabolic agents and peptide hormones in accordance with the Drug Administration Law of the People’s Republic of China, Customs Law of People's Republic of China, Anti-doping Regulations and other relevant laws and administrative regulations.

Article 2 The State adopts license control on the import and export of anabolic agents and peptide hormones.

Article 3 The importer shall apply for the importation of anabolic agents and peptide hormones to the State Food and Drug Administration.

Article 4 For the importation of anabolic agents and peptide hormones for medical purpose, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Copy of the Import Drug License (or the Pharmaceutical Product License) (original or duplicate);
(4) Copy of the Drug Supply Certificate, Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importer; to import drug substance and intermediate preparations including preparations to be repackaged in China for their own needs, drug manufacturers shall submit copies of the Drug Manufacturing Certificate, Corporate Business License and Organization Code Certificate;
(5) Where holders of the Import Drug License (or the Pharmaceutical Product License) entrust other companies to export their drugs, they shall provide the authorization letter for export.

All copies mentioned above should be stamped with the official seal of the importer.

Article 5 For the importation of anabolic agents and peptide hormones for teaching and scientific research purposes, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Certificates of legitimate qualifications of users in China, calculation basis for the quantity of the drug in use and letter of guarantee issued by the user for legitimate use and management of the drug;
(4) Approval documents for relevant scientific research projects or approval documents of relevant competent authority;
(5) Where entrusted by users for importation, importers shall provide copies of the authorization agreement, the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importers.

All copies mentioned above should be stamped with the official seal of the importer.

Article 6 Where a enterprise in China entrusted by an overseas enterprise for contract manufacturing needs to import anabolic agents and peptide hormones, it shall provide materials required in Items (1), (3) and (5) of Paragraph 1 of Article 5, in addition, official documents to prove recorded by the local (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government.

All copies mentioned above should be stamped with the official seal of the importer.

Article 7 The State Food and Drug Administration shall decide whether or not to approve the import within 15 working days after receiving the application for import and the relevant materials. Where the application is approved, the State Food and Drug Administration shall issue the Import License for the drug; where the application is not approved, the State Food and Drug Administration shall give reasons in writing.

Article 8 The importer may declare to the customs of the ports where drug importation is permitted upon presenting the Import License for the drug issued by the State Food and Drug Administration. The customs shall clear the drug in the presence of the Import License for the drug.
The Drug Import Note is not required for import of anabolic agents and peptide hormones.

Article 9 To import anabolic agents and peptide hormones including those sold in China for the first time for medical purpose, the importer shall fill in the Import Drug Clearance Form timely after going through the import formalities and submit the following materials in duplicate to the (food and) drug regulatory department where the port of entry is located, upon presenting the original Import Drug License (or the Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug, to apply for the Notice of Import Drug Port Test:
(1) Copies of the Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the Import License for the drug;
(2) Copies of the Drug Manufacturing Certificate or Drug Supply Certificate, and Copy of the Business License for Enterprises as a Legal Person.
(3) Copy of the certificate of origin;
(4) Copy of the purchasing contract;
(5) Copies of packing list, bill of lading and freight invoice;
(6) Copy of the certificate of analysis;
(7) Format of drug insert sheet, package and label (except for drug substance and intermediate preparation);

All copies mentioned above should be stamped with the official seal of the importer.

Article 10 After checking the received Import Drug Clearance Form and relevant materials, the port (food and) drug regulatory department shall return the original Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug to the importer, and send the Notice of Import Drug Port Test, along with a copy of the dossier as prescribed in Article 9 of the Provisions, to the port drug testing institute on the same day.

After receiving the Notice of Import Drug Port Test, the port drug testing institute shall contact the importer within two working days and conduct sampling on the storage site. Upon the completion of the sampling, the mark “sampled” shall be stamped on the back of the first page of the original Import License for the drug, with the seal of sampling institute affixed.

Article 11 Anabolic agents and peptide hormones imported for teaching and research purposes or for the domestic manufacturing contracted by overseas enterprises are exempted from testing.

Article 12 The port (food and) drug regulatory department shall report timely to the State Food and Drug Administration in any of the following circumstances:
(1) The port (food and) drug regulatory department refuses to issue the Notice of Import Drug Port Test in accordance with the provisions in Article 17 of the Provisions for Import Drug (Decree No. 4 of the State Food and Drug Administration and the General Administration of Customs);
(2) The port (food and) drug testing institute refuses the sampling in accordance with the requirements in Article 25 of the Provisions for Import Drug.

The port (food and) drug regulatory department shall take mandatory administrative measures to seal up or seize all the imported drugs within the situations prescribed in the previous paragraph. It shall make the decision of allowing shipping back within seven days from the date of the seal-up or seizure, and inform the importer of applying for the Export License for the drug according to the export procedures for anabolic agents and peptide hormones prescribed in the Provisions and return all the import drugs to the original exporting country.

Where the importer fails to respond or make clear its intention to ship back the drugs within ten days after being informed of the decision, the sealed up or seized drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.

Article 13 For imported anabolic agents and peptide hormones out of specifications upon testing by the port drug testing institute, the importer shall provide a detailed report about the distribution and use of all the imported drugs to the port (food and) drug regulatory department where the importer is located within two days after receiving the Import Drug Test Report.

After receiving the Import Drug Test Report, the port (food and) drug regulatory departments shall take mandatory administrative measures to timely seal up or seize all the drugs and, within seven days, decide whether or not to place the case on file.

Where the importer fails to apply for a retesting within the specified timeline or the result of the retesting is still out of specifications, the port (food and) drug regulatory department shall make the decision of allowing shipping back and notify the importer to apply for the Export License for the drug according to export procedures for anabolic agents and peptide hormones prescribed in the Provisions to return all the imported drugs to the original exporting country. Where the importer fails to respond or make clear its intention to ship back the drugs within ten days from the date of receiving the decision, the drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.

Where the result of retesting is in compliance with the specifications, the port (food and) drug regulatory department shall remove the mandatory administrative measures of seal-up and seizure.

The port (food and) drug regulatory department shall handle the case according to the provisions in Paragraph 2, Paragraph 3 and Paragraph 4 of this Article and report the result to the State Food and Drug Administration, and, at the same time, notify the (food and) drug regulatory departments of provinces, autonomous regions and municipalities directly under the Central Government as well as other port (food and) drug regulatory departments.

Article 14 Where domestic drug manufacturers, distributors and medical institutions purchase imported anabolic agents and peptide hormones, the supplier shall provide copies of the Import Drug License (or Pharmaceutical Product License), the Import License for the drug and the Import Drug Test Report, and affix its official seal to the abovementioned copies.

Article 15 The exporter shall apply for exportation of anabolic agents and peptide hormones to the (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government, where it is located, and submit the following materials:
(1) Application Form for Drug Export;
(2) Original import permit (or its copy with notarization) provided by the drug regulatory authority of the importing country or region.
If the importing country or region has no license system in the importation of anabolic agents and peptide hormones, the exporter shall provide the official document (original) of the drug regulatory authority of the importing country or region to prove that the import of the drugs of this type is exempted from the import permit, along with one of the following documents:
a. Original official document (or its copy with notarization) granting import provided by the drug regulatory authority of the importing country or region;
b. Certificates of legitimate qualifications of importers and original supporting document (or its copy with notarization) proving legitimate use of the drug;
(3) Copy of the purchasing contract or order form (except for manufacturers that export their own products);
(4) Copy of the export contract or order form;
(5) Where the export drug is an approved one produced by a domestic manufacturer, the Drug Manufacturing Certificate and Business License for Enterprises as a Legal Person of the manufacturer and a copy of the approval document of the drug shall be provided;
Where the export drug is produced by a domestic enterprise under contract of an overseas enterprise, the exporter shall provide a copy of the official document to prove recorded by the local (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government.
(6) Copies of the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the exporter.

All copies mentioned above should be stamped with the official seal of the exporter.

Article 16 Where the drugs are to be shipped back in accordance with the requirements in Article 12 and Article 13 of the Provisions, the exporter shall provide the following materials to apply for the Export License for the drug:
(1) Documents proving the request for return of goods made by the original exporter of the exporting country;
(2) Import License for the drug.

Article 17 The (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government shall decide whether or not to approve the export within 15 working days after receiving the export application and relevant materials.

Where the application is approved, the regulatory department shall issue the Export License for the drug; where the application is not approved, the regulatory department shall give reasons in writing.

Where the Export License for the drug is applied for in accordance with the requirements in Article 16 of the Provisions, the issuing authority shall mark “return of the original goods” on the Export License for the drug.

Article 18 The exporter may go through the customs formalities upon presenting the Export License for the drug issued by the (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government. The customs shall clear the drug in the presence of the Export License for the drug.

Article 19 The importer and exporter shall provide one more sheet of customs declaration form and apply for sign-back of the sheet when going through the customs formalities. The customs shall stamp the “proof seal” on the sheet in the presence of the Import License for the drug and Export License for the drug. The customs shall charge the cost according to the relevant regulations for issuing certificates.

The importer and exporter shall return the first sheet of the Import License for the drug or Export License for the drug along with the customs declaration form with the seal of the customs, to the issuing regulatory department within one month after completing the import and export.

Where the importer or exporter conducts no relevant importation or exportation after obtaining the Import License for the drug and Export License for the drug, the importer or exporter shall return the original license to the issuing regulatory department within one month after expiration of the license.

Article 20 The validation of the Import License for the drug is one year; the validation of the Export License for the drug is no more than three months (valid within the calendar year).

“One license for one customs clearance” is implemented for the Import License for the drug and Export License for the drug. The license shall be used only once within the validation and its content shall not be altered. Where the import or export is postponed for some reasons, the importer or exporter may request for a new license once with the original one.

Article 21 Where the Import License for the drug or Export License for the drug is lost, the importer or exporter shall report the loss to the original issuing authority in writing immediately. After receiving the loss report, the original issuing authority shall notify the port customs and reissue the license if no harmful consequences are found through confirmation.

Article 22 The Import License for the drug and Export License for the drug are uniformly printed by the State Food and Drug Administration.

Article 23 Where anabolic agents and peptide hormones are imported or exported in the form of processing trade, the customs shall go through and supervise the clearance formalities upon presentation of the Import License for the drug or Export License for the drug. Those not exported for special reasons shall be transferred to and handled by the local (food and) drug regulatory department in accordance with relevant regulations, and the customs shall conduct the verification and cancellation procedures in the presence of relevant documents.

Article 24 Anabolic agents and peptide hormones entering or leaving between bonded zones, export processing zones, other special Customs controlling areas, Customs bonded and controlling areas, with overseas, or between the special Customs controlling areas and the Customs bonded and controlling areas are exempt from application for the Import License for the drug or Export License for the drug, and supervised by the Customs.

Import License for the drug shall be applied for anabolic agents and peptide hormones entering from bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas into other places in China.

Export License for the drug shall be applied for anabolic agents and peptide hormones entering bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas from other places of China.

Article 25 Where an individual carries or mails anabolic agents and peptide hormones, within a reasonable amount, into or out of China for medical needs, the customs shall clear the drugs in the presence of prescriptions of medical institutions in accordance with relevant regulations on prescriptions of the competent health department.

Article 26 Besides prescribed in the Provisions, the importation, port test, supervision and control of anabolic agents and peptide hormones for medical purpose are implemented with reference to requirements related to drug importation in the Provisions for Drug Importation.

Article 27 Anabolic agents and peptide hormones imported for medical purpose mentioned in the Provisions refer to the import anabolic agents and peptide hormones to be used for preparation production or to be marketed in China.

Importer refers to the importer specified on the Import License for the drug obtained in accordance with the Provisions.

Exporter refers to the exporter specified on the Export License for the drug obtained in accordance with the Provisions.

Article 28 These Provisions shall go into effect as of September 1, 2006. The Notice on Import and Export of Anabolic Agents and Peptide Hormones (Guo Shi Yao Jian An [2004] No. 474) issued by the State Food and Drug Administration on September 30, 2004 shall be annulled therefrom.


中国农业银行


中国农业银行关于印发《中国农业银行结售汇业务管理办法》的通知
1996年11月25日，中国农业银行

各省、自治区、直辖市分行，各计划单列市分行：
现将《中国农业银行结售汇业务管理办法》印发给你们，请严格遵照执行并将此办法转发辖属分支行。《关于下发〈中国农业银行结售汇业务管理暂行办法〉的通知》（农银发〔1994〕69号）同时废止。

附：中国农业银行结售汇业务管理办法

第一章 总 则
第一条 为加强我行结售汇业务的管理，更好地执行人民银行《结汇、售汇及付汇管理规定》，结合我行结售汇业务实际情况，特制定本办法。
第二条 本办法适用于经批准可办理国际结算业务的分支行。
第三条 上述分支行应按照本办法的规定办理结汇、售汇、付汇及进口付汇核销业务。

第二章 经常项目下的结汇
第四条 境内机构收入的下列外汇均应办理结汇：
一、出口或先支后收转口货物及其他交易行为收入的外汇；
二、境外贷款项下国际招标中标收入的外汇；
三、海关监管下境内经营免税商品收入的外汇；
四、交通运输（包括各种运输方式）及港口（含空港）、邮电（不包括国际汇兑款）、广告、咨询、展览、寄售、维修等行业及各类代理业务提供商品或者服务收入的外汇；
五、行政、司法机关收入的各项外汇规费、罚没款等；
六、土地使用权、著作权、商标权、专利权、非专利技术、商誉等无形资产转让收入的外汇，但上述无形资产属于个人所有的，可不结汇；
七、境外投资企业汇回的外汇利润、对外经援项下收回的外汇和境外资产的外汇收入；
八、对外索赔收入的外汇、退回的外汇保证金等；
九、出租房地产和其他外汇资产收入的外汇；
十、保险机构受理外汇保险所得的外汇收入；
十一、取得《经营外汇业务许可证》的金融机构经营外汇业务的净收入；
十二、国外捐赠、资助及援助收入的外汇；
十三、除外商投资企业外，向境外发售房地产及其他资产收入的外汇；
十四、国家外汇管理局规定的其他应当结汇的外汇。
第五条 境内机构（除外商投资企业）的下列外汇，可经外汇局批准后，在我行开立外汇帐户，定期进行结汇：
一、经营境外承包工程、向境外提供劳务、技术合作及其他服务业务的公司在上述项目进行过程中收到的业务往来外汇，净收入按年结汇；
二、保险机构受理外汇保险，须向境外分保及尚未结算的保费，净收入按年结汇；
三、一类旅行社收取国外旅游机构预付的外汇不超过上年收汇总额3％（由外汇局核定数额）可存入其暂收待付帐户，其余的外汇均结汇；
四、从事代理对外或者境外业务的机构代收代付的外汇，净收入按季结汇；
五、除本条第三款的规定以外，其他暂收待付或者暂收待结项下的外汇，净收入按季结汇。
第六条 外商投资企业经营项目下外汇收入可在外汇管理局核定的最高金额以内保留外汇，超出部分我行暂时入帐，同时通知企业在5个工作日内结汇，或通过外汇调剂中心卖出。
第七条 境内机构的贸易出口收汇按以下办法结汇或入帐：
一、以跟单信用证／保函和跟单托收方式结算的出口收汇，凭合同及上述结算方式规定的有效商业单据和出口单位提供的出口收汇核销单编号办理结汇或入帐；
二、以汇款方式结算的出口收汇，凭正本出口收汇核销单办理结汇或入帐；
三、出口项下预收货款凭未加盖海关“验讫”章的正本出口收汇核销单结汇或入帐；
四、出口押汇结汇，比照信用证项上结汇办法办理；
五、出口信用保险和其他出口货物保险所得的理赔款，凭出口收汇核销单结汇或入帐；
六、对于不符合上述要求的收汇，我行应将原币划入银行暂收专户，在自收汇日起的3个工作日内通知收汇单位提供凭证，以便办理结汇或入帐。
第八条 对于境内机构从事非贸易活动收取的外币现钞，我行凭外汇管理局的核准件结汇；对于从事对外贸易活动收取的现钞，凭合同、发票、加盖海关“验讫”章的出口收汇核销单、海关签章的入境申报单正本办理结汇。超过等值1万美元的现钞结汇，应办理结汇登记并按季向外汇管理局报送报表。
第九条 国外捐赠、资助及援助收入的外汇，除合同规定用于境外支付，并经外汇管理局批准可予保留的以外，均办理结汇。
第十条 外国驻华使领馆、国际组织、境外法人、驻华机构、居民个人及来华人员的外汇，可不办理结汇。
第十一条 境内机构出口押汇款项和中资企业借入的国际商业贷款不予结汇。
第十二条 境内机构下列范围内的外汇，未经外汇管理局批准，不得办理结汇：
一、境外法人或自然人作为投资汇入的外汇；
二、境外借款及发行外币债券、股票取得的外汇；
三、经外汇局批准的其他资本项目下的外汇收入。

第三章 经常项目下的售汇及付汇
第十三条 境内机构下列贸易及非贸易经营性用汇，持下列有关有效商业单据和有效凭证从其外汇帐户中支付或在我行兑付：
一、用跟单信用证／保函方式结算的贸易进口，在开证时，凭进口合同、进口付汇核销单、开证申请书购汇；在付汇时购汇，还应提供该结算方式要求的有效商业单据。
二、用跟单托收方式结算的贸易进口，凭进口合同、进口付汇核销单、进口付汇通知书及该结算方式要求的有效商业单据办理售汇。
三、用汇款方式结算的贸易进口，凭进口合同、进口付汇核销单、发票、正本进口货物报关单、正本运输单据。若提单上的“提货人”和报关单上的“经营单位”与进口合同中列明的买方名称不一致，还应提供两者间的代理协议。若不能提供正本报关单的，凭外汇管理局核准件办理。
四、进口项下的预付货款，不超过合同总金额的15％或不超过等值10万美元的，凭进口合同、进口付汇核销单办理，超过上述比例或金额的，凭外汇管理局的核准件办理。
五、上述一至四项下进口，实行进口配额管理或者特定产品进口管理的货物，还应提供有关部门签发的许可证或进口证明，实行自动登记制的货物进口，应提供登记表格。
六、进口项下的尾款，审核进口合同、进口付汇核销单、验货合格证明。
七、出口项下不超过合同总金额2％的暗佣和5％的明佣，或不超过等值1万美元的佣金，凭出口合同或佣金协议、结汇水单或收帐通知，超出上述规定的，凭外汇管理局核准件办理。
八、出口项下对外退赔外汇，凭结汇水单或收帐通知、理赔协议和外汇管理局出具的“已冲减出口收汇核销证明”。
九、进出口项下的运输费、保险费，凭进口或出口合同、正本运输费收据和保险费收据。
十、进出口项下的资料费、技术费、信息费等从属费用，凭进口或出口合同、进口付汇核销单或出口收汇核销单、发票或收费单据及进口或出口单位负责人签字的说明书。
十一、先支后收转口贸易项下的外汇支付，凭外汇管理局核准件办理。
十二、从保税区购买商品及购买国外入境展览展品的用汇，视同进口项下用汇。
十三、专利权、著作权、商标、计算机软件等无形资产的进口，赁进口合同或协议。
十四、境外承包工程所需的投标保证金，凭投标文件；履约保证金及垫付工程款项，凭合同办理。
十五、捐赠进口项下、易货贸易项下、来料加工项下的购汇或对外支付，以及贸易项下购汇企业无对外贸易经营权的，凭外汇管理局核准件办理。
第十四条 下列贸易及非贸易经营性对外支付，凭客户提供的支付清单先从其外汇帐户中支付或在我行兑付，事后核查：
一、经国务院批准的免税品公司按照规定范围经营免税商品的进口支付；
二、民航、海运、铁道部门（机构）支付境外国际联运费、设备维修费、站场港口使用费、燃料供应费、保险费、非融资性租赁费及其他服务费用；
三、民航、海运、铁道部门（机构）支付国际营运人员伙食、津贴补助；
四、邮电部门支付国际邮政、电信业务费用。
第十五条 机关、事业单位和社会团体财政预算内的非贸易非经营性用汇，按照《非贸易非经营性外汇财务管理暂行规定》办理。
第十六条 境内机构财政预算外的下列非经营性用汇，凭下列正本有效凭证从其外汇帐户中支付或在我行兑付；
一、在境外举办展览、招商、培训及拍摄影视片等用汇，凭合同、境外机构的支付通知书及主管部门批准文件；
二、对外宣传费、对外援助费、对外捐赠外汇、国际组织会费、参加国际会议的注册费、报名费，凭主管部门的批件及有关函件；
三、在境外设立代表处或者办事机构的开办费和年度预算经费，凭主管部门批准设立机构的批件和经费预算书；
四、国家教委国外考试协调机构支付境外的考试费，凭对外合同及国外考试机构的帐单或结算通知书；
五、在境外办理商标、版权注册、申请专利和法律、咨询服务等所需费用，凭合同和发票；
六、因公出国费用，凭国家授权部门的出国任务批件；
七、除上述六项以外的非经营性用汇，凭外汇管理局核准件办理。
第十七条 境内机构偿还境内金融机构自营外汇贷款本息，凭《外汇（转）贷款登记证》、借贷合同及债权机构还本付息通知单，从其外汇帐户中支付或在我行兑付。
第十八条 外商投资企业外方投资者利润、红利的汇出，凭董事会利润分配决议书从其外汇帐户中支付或在我行兑付；企业中外籍、华侨、港澳台职工纳税后的正当收益，凭证明材料在我行兑付。
第十九条 按规定以外币支付的股息，凭董事会利润分配决议书从其外汇帐户中支付或在我行兑付。
第二十条 居民个人因私兑换外汇以及驻华机构、来华人员人民币收入的兑付，国家外汇管理局授权由中国银行办理，我行暂不办理此项业务。临时来华人员凭本人护照、原兑换水单（有效期6个月），可在我行兑回外汇。
第二十一条 对于超过等值1万美元的现钞提取，须凭外汇管理局的核准件办理。
第二十二条 不在当地注册的境内机构需在我行购汇的，须凭注册所在地外汇管理局核准件办理。
第二十三条 所有付汇应在有关结算方式或合同规定的日期办理，不得提前对外付款；需提前偿还境外债务本息的，应凭外汇管理局批准件办理。
第二十四条 从外汇帐户对外支付的，我行应根据规定的帐户收支范围进行审核，符合规定的再办理支付。

第四章 资本项目下的结汇、售汇与付汇
第二十五条 境内机构偿还外债本息，对外担保履约用汇，境外投资资金的汇出，外商投资企业的中方投资者需以外汇投入的注册资金，以及外商投资企业的外汇资本金的增加、转让等，均凭外汇管理局核准件从其外汇帐户中支付或在我行兑付。
第二十六条 在我行开有外汇帐户的境内机构其资本项目下的外汇，应按以下规定办理：
一、下列范围内的外汇，未经外汇管理局批准，不得结汇：
（一）境外法人或自然人作为投资汇入的外汇；
（二）境外借款及发行外币债券、股票取得的外汇；
（三）经国家外汇管理局批准的其他资本项目下外汇收入。
除出口押汇外的国内外汇贷款和中资企业借入的国际商业贷款不得结汇。
二、向境外出售房地产及其他资产收入的外汇，除本规定第六条限定的数额外，应在我行结汇。
第二十七条 在我行开有外汇帐户的境内机构偿还境内中资金融机构外汇贷款本金，持《外汇（转）贷款登记证》、借贷合同及债权机构的还本通知单，我行可从其外汇帐户中支付或者给予兑付。
第二十八条 在我行开有外汇帐户的境内机构资本项目下的下列用汇，持所列有效凭证向外汇管理局申请，我行凭外汇管理局的核准件从其外汇帐户中支付或给予兑付：
一、偿还外债本金，持《外债登记证》、借贷合同及债权机构还本通知单；
二、对外担保履约用汇，持担保合同、外汇管理局核发的《外汇担保登记证》及境外机构支付通知；
三、境外投资资金的汇出，持国家主管部门的批准文件和投资合同；
四、外商投资企业的中方投资者经批准需以外汇投入的注册资金，持国家主管部门的批准文件和合同。
第二十九条 外商投资企业的外汇资本金的增加、转让或者以其他方式处置，持董事会决议，经外汇管理局核准后，我行可从其外汇帐户中支付或给予售汇。
投资性外商投资企业外汇资本金在境内投资及外方所得利润在境内增资或者再投资，我行须凭外汇管理局核准件方可办理。

第五章 进口售付汇核销
第三十条 凡以售汇或从外汇帐户支付方式在我行办理有关商品的货款、预付款、尾款、资料费等对外支付的客户，均应在我行办理售付汇核销。
第三十一条 除预付货款外的售付汇，进口单位在购付汇时有报关单的，同时办理核销；在购付汇时没有报关单的，在30个工作日内办理核销。预付货款项下的售付汇，待合同余款办理售付汇时，一并核销。
第三十二条 无形贸易进口项下的资料费、技术费、信息费等的进口售付汇，我行凭进口核销单、进口合同、发票、进口单位负责人签字的情况说明及其他有关商业单据办理核销手续。
第三十三条 转口贸易项下的进口售付汇，我行凭转口后所得外汇的结汇水单或收帐通知以及有关情况说明办理核销手续。转口后所得外汇的结汇或收帐金额须大于原售付汇金额。
第三十四条 除上述第二十八条、第二十九条的规定外，其他进口核销单项下的进口售付汇，我行均须凭正本进口货物报关单办理核销。报关单上货物金额、品名、经营单位必须与核销单一致。对于有疑点的进口货物报关单和一次售付汇金额超过50万美元的，须向报关单的签发海关进行核对。
对于分笔付汇一次到货报关的，报关单的货物金额应等于所有核销单的付汇总额。
对于一次付汇分批到货报关的，则所有报关单上的货物金额之和应等于核销单上的付汇金额。
第三十五条 部分到货或部分退货的，我行凭退回外汇的结汇水单或收帐通知、有关情况说明及相应的报关单办理核销。
因故不能到货的，我行凭退回外汇的结汇水单或收帐通知及情况说明办理核销。
第三十六条 我行应对逾期未核销的进口单位进行催办，对仍不办理核销的按月报送外汇管理局。

第六章 结汇、售汇及付汇业务的管理
第三十七条 我行可在外汇部门批准后，按规定为有远期支付合同或偿债协议的用汇单位办理人民币与外币的远期买卖及其他保值业务，以避免汇率风险。
第三十八条 各级行按照每日总行公布的外汇／人民币牌价办理结售汇业务，金额为100万美元以上的大额结售汇可在总行公布的买卖价格幅度内与客户面议。
第三十九条 易货贸易项下进口，未经外汇管理局批准，我行不得给予售汇或从外汇帐户中支付。
第四十条 各分行应根据自身业务情况，制定相应的售汇审批授权额度，业务经办人员、结算部经理、总经理分级授权，各分行应为辖属分支行制定相应的额度。
第四十一条 各级行应建立结售汇内部监管制度，遇有结售汇异常情况，应及时向外汇管理局当地分支局及总行报告。
第四十二条 各级行应根据人民银行、外汇管理局及总行的规定及时上报各项业务报表。
第四十三条 各级行应将办理上述各项业务的有关单证建立档案并妥善保管，档案保存期5年。

第七章 附 则
第四十四条 本办法如与人民银行、外汇管理局有关规定有出入，以人民银行、外汇管理局规定为准。
第四十五条 本办法由总行国际业务部负责解释、修改。
第四十六条 本办法自下发之日起执行。原农银发〔1994〕69号文同时废止。